Skip to main content

JP Morgan downgrades Pfizer, saying stock has moved too far, too fast: 'Moving to the sidelines'

J.P. Morgan downgraded Pfizer shares to neutral from overweight on Tuesday, warning clients that the stock's 2018 run up will likely slow.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.